WOOJUNG BIO, Inc (215380) Fair Value & Analysis
Healthcare · KR · Market cap 42.2B KRW
Fair value as of: Jun 24, 2026
Analysis
WOOJUNG BIO, Inc (215380) currently trades at 2,220 KRW, while our model-based Fair Value estimate is 2,524 KRW — implying the stock looks roughly 13.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
WOOJUNG BIO, Inc. engages in the various research services in South Korea. The company provides LAB CLOUD, a bio-specialized accelerator and research platform; and efficacy evaluation, clinical and histopathology, general and inhalation toxicology, behavioral test, bioanalytical, organoids, ADME, NMR analysis, SPR analysis, IND package, shared lab animal facility, breeding lab, microbial and environmental monitoring, and technical support services. In addition, It offers construction and implementation, infection control, maintenance, laboratory and pharmaceutical equipment, and consumables and animal resourcing services. The company was founded in 1989 and is based in Hwaseong-si, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is WOOJUNG BIO, Inc (215380) undervalued?
What is the fair value of 215380?
What is the quality score of 215380?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.